NEOGEN Neogen Chemicals Q1 FY27 results (Apr–Jun 2026) and concall
Neogen Chemicals reported a strong Q1 FY27 with consolidated revenue up 34% to INR 250 crore and PAT up 67% to INR 17.1 crore, driven by robust performance in both base and battery chemicals segments. EBITDA margins expanded to 19.3%. The company is progressing with its Dahej plant reconstruction and battery chemicals capacity ramp-up, while also planning a INR 600 crore QIP to reduce debt and fund future growth opportunities.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
Q1 FY27: revenue up 640.0%, net profit up 35.7% against the same quarter last year.
| Line item | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|
| Revenue | 22 | -3 | 5 | 7 | 8 −64% | 22 +833% | 37 +640% |
| EBITDA | 38 | 41 | 35 | 35 | 36 −5% | 45 +10% | 48 +37% |
| Net profit | 14 | 5 | 14 | 9 | 9 −36% | 15 +200% | 19 +36% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
